Stockreport

Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF focused on providing therapies for people living with rare disease, today announces the publication of “Mechanistic insights into arimoclomol mediated effects on lysosom [Read more]